In vitro activities of two novel oxazolidinones (U100592 and U100766), a new fluoroquinolone (trovafloxacin), and dalfopristin-quinupristin against Staphylococcus aureus and Staphylococcus epidermidis.

Gelijkaardige items

• In vitro activities of oxazolidinone compounds U100592 and U100766 against Staphylococcus aureus and Staphylococcus epidermidis.
  door: Kaatz, G W, et al.
  Gepubliceerd in: (1996)
• In vitro activities of the oxazolidinone antibiotics U-100592 and U-100766 against Staphylococcus aureus and coagulase-negative Staphylococcus species.
  door: Jorgensen, J H, et al.
  Gepubliceerd in: (1997)
• In vitro activities of U-100592 and U-100766, novel oxazolidinone antibacterial agents.
  door: Zurenko, G E, et al.
  Gepubliceerd in: (1996)
• In vitro antimicrobial activities and spectra of U-100592 and U-100766, two novel fluorinated oxazolidinones.
  door: Jones, R N, et al.
  Gepubliceerd in: (1996)
• In vitro activities of oxazolidinones U-100592 and U-100766 against penicillin-resistant and cephalosporin-resistant strains of Streptococcus pneumoniae.
  door: Mason, E O, et al.
  Gepubliceerd in: (1996)